Co-existence of Phenylketonuria and Fabry disease on a 3 year-old boy: case report

被引:6
作者
Concolino, Daniela [2 ]
Rapsomaniki, Maria [2 ]
Disabella, Eliana [3 ]
Sestito, Simona [2 ]
Pascale, Maria G. [2 ]
Moricca, Maria T. [2 ]
Bonapace, Giuseppe [2 ]
Arbustini, Elisea [3 ]
Strisciuglio, Pietro [1 ]
机构
[1] Univ Naples Federico II, Dept Pediat, Naples, Italy
[2] Magna Graecia Univ Catanzaro, Dept Pediat, Catanzaro, Italy
[3] IRCCS Policlin San Matteo, Ctr Inherited Cardiovasc Dis, Pavia, Italy
关键词
CHILDREN; ALPHA;
D O I
10.1186/1471-2431-10-32
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The co-existence of two genetically distinct metabolic disorders in the same patient has rarely been reported. Phenylketonuria (PKU) is an inborn error of the metabolism resulting from a phenylalanine hydroxylase deficiency. Fabry disease (FD) is an X-linked lysosomal storage disorder due to a deficiency of the enzyme alpha-galactosidase A. Case presentation: We report a case of a 3 year-old boy affected by classic PKU and FD, both confirmed by molecular data. The FD was suspected at the age of 21 months on the presence of non-specific GI symptoms (severe abdominal pain and periodically appearance of not specific episodes of gastroenteritis) apparently non related to PKU. Conclusion: This is the first report of co-existence of FD and PKU, two different congenital inborn of metabolism and in consideration of the prevalence of each disease this chance association is a very unusual event. The co-existence of this diseases made very difficult the correct interpretation of clinical symptoms as lack of appetite, severe abdominal pain and non-specific gastroenteritis episodes. Furthermore, this case report helps to define the early clinical phenotype of FD.
引用
收藏
页数:3
相关论文
共 8 条
[1]  
Ashton-Prolla P, 2000, J INVEST MED, V48, P227
[2]   Fabry disease in childhood [J].
Desnick, RJ ;
Brady, RO .
JOURNAL OF PEDIATRICS, 2004, 144 (05) :S20-S26
[3]   FEEDING PROBLEMS IN YOUNG PKU CHILDREN [J].
MACDONALD, A ;
RYLANCE, GW ;
ASPLIN, DA ;
HALL, K ;
HARRIS, G ;
BOOTH, IW .
ACTA PAEDIATRICA, 1994, 83 :73-74
[4]   Enzyme replacement therapy with agalsidase alfa in children with Fabry disease [J].
Ramaswami, U. ;
Wendt, S. ;
Pintos-Morell, G. ;
Parini, R. ;
Whybra, C. ;
Leon Leal, J. A. ;
Santus, F. ;
Beck, M. .
ACTA PAEDIATRICA, 2007, 96 (01) :122-127
[5]   Clinical manifestations of Fabry disease in children: Data from the Fabry outcome survey [J].
Ramaswami, U ;
Whybra, C ;
Parini, R ;
Pintos-Morell, G ;
Mehta, A ;
Sunder-Plassmann, G ;
Widmer, U ;
Beck, M .
ACTA PAEDIATRICA, 2006, 95 (01) :86-92
[6]   Natural history of Fabry disease in males: preliminary observations [J].
Schiffmann, R .
JOURNAL OF INHERITED METABOLIC DISEASE, 2001, 24 :15-17
[7]  
SCRIVER CR, 2001, VOGELSTEIN BL MCGRAW, P1667
[8]   High incidence of later-onset Fabry disease revealed by newborn screening [J].
Spada, Marco ;
Pagliardini, Severo ;
Yasuda, Makiko ;
Tukel, Turgut ;
Thiagarajan, Geetha ;
Sakuraba, Hitoshi ;
Ponzone, Alberto ;
Desnick, Robert J. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2006, 79 (01) :31-40